跳至主要内容
临床试验/NL-OMON44747
NL-OMON44747招募中不适用

Reducing costs of surveillance of patients with non-muscle invasive bladder cancer. - URICA II

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 435 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
435

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) (Previous) primary NMIBC
  • 2) Currently under surveillance for possible recurrent disease
  • 3) Monitored by the urology patient archives in the participating hospitals

排除标准

  • 1) Patients upgraded at reTUR to MIBC
  • 2) Patients presenting with MIBC
  • 3) Patients below 21 years of age. ;After the initial TUR, a second TUR (reTUR) is recommended for patients with pT1 tumors. This is to establish whether resection was radical and when there is remaining tumor whether the tumor is muscle-invasive. In the latter case these patients will be excluded because they do not belong to the NMIBC category

研究者

相似试验